Bill Miller’s Bristol-Myers Squibb BMY Stock Holding History

Bill Miller’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4M	Hold	69,500	–	–	0.95%	30
2026 Q1	$4.22M	Sell	69,500 -38,500	-36%	-$2.24M	1.1%	28
2025 Q4	$5.83M	Hold	108,000	–	–	2.05%	18
2025 Q3	$4.87M	Hold	108,000	–	–	1.79%	24
2025 Q2	$5M	Hold	108,000	–	–	2.12%	21
2025 Q1	$6.59M	Hold	108,000	–	–	3%	12
2024 Q4	$6.11M	Buy	108,000 +28,000	+35%	+$1.56M	2.61%	17
2024 Q3	$4.14M	Buy	80,000 +20,000	+33%	+$938K	2.34%	21
2024 Q2	$2.49M	Hold	60,000	–	–	1.59%	21
2024 Q1	$3.25M	Buy	+60,000	New	+$3.06M	2.08%	18

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bill Miller's BMY Position: Q2 2026 in Review

Bill Miller held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 69,500 shares worth $4M. The position accounts for 0.95% of the portfolio, ranked #30.

Bill Miller first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.59M in Q1 2025. 2,506 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Bill Miller held 69,500 shares of Bristol-Myers Squibb worth $4M as of Q2 2026.
Bill Miller left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.95% of Bill Miller's portfolio in Q2 2026, its #30 holding.
Bill Miller first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
Bill Miller's Bristol-Myers Squibb position peaked at $6.59M in Q1 2025.
2,506 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Miller Value Partners's 13F filing for Q2 2026, filed 14 Aug 2026.